Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 474.00
Bid: 470.00
Ask: 472.00
Change: 6.00 (1.28%)
Spread: 2.00 (0.426%)
Open: 467.00
High: 474.00
Low: 467.00
Prev. Close: 468.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Treatt (TET): Sweet upgrades

19 May 2021 07:00

Edison Investment Research Limited Treatt (TET): Sweet upgrades 19-May-2021 / 07:00 GMT/BST


 

London, UK, 19 May 2021

 

Treatt (TET): Sweet upgrades

Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management and culture of the business, which has been transformed under CEO Daemmon Reeve's nine years at the helm. Both sales and profit performance are impressive, and we once again raise our forecasts, as the 'healthier' categories continue to outperform. The relocation of the UK business is under way, and we expect the business to continue to perform well once the new UK capacity comes on stream.

 

Treatt trades at 40.7x and 28.1x FY21 P/E and EV/EBITDA, representing premiums of c 30% and c 40% respectively to its peers. We note that the current share price is discounting medium-term sales growth of 5.0%, falling to 2.5% in perpetuity, with a WACC of 5.7% and a terminal EBIT margin of 20.0%. We forecast net debt at end FY21, moving to a net cash position thereafter, and hence expect a significant uplift in the dividend in FY21.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Sara Welford +44 (0)20 3077 5700 consumer@edisongroup.com

Russell Pointon +44 (0)20 3077 5700 consumer@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1198024 19-May-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM
16th Apr 20141:41 pmRNSNotice of EGM
9th Apr 20142:34 pmRNSDirector/PDMR Shareholding
7th Apr 201410:56 amRNSNotice of EGM
24th Feb 20145:12 pmRNSResult of AGM
10th Feb 20147:00 amRNSInterim Management Statement
31st Dec 20137:00 amRNSAnnual Information Update
23rd Dec 20134:35 pmRNSDirector/PDMR Shareholding
19th Dec 201310:32 amRNSAnnual Financial Report
13th Dec 20139:48 amRNSDirector/PDMR Shareholding
9th Dec 20137:00 amRNSFinal Results
22nd Oct 20134:22 pmRNSDirector/PDMR Shareholding
17th Oct 20132:53 pmRNSDirector/PDMR Shareholding
30th Sep 201312:54 pmRNSVoting Rights and Capital
30th Sep 20137:00 amRNSTrading Statement
26th Sep 20133:17 pmRNSDirector/PDMR Shareholding
13th Sep 201310:54 amRNSHolding(s) in Company
3rd Sep 20139:23 amRNSDirector/PDMR Shareholding
1st Aug 20137:00 amRNSInterim Management Statement
31st Jul 20132:14 pmRNSVoting Rights and Capital
29th Jul 201310:48 amRNSDirector/PDMR Shareholding
23rd Jul 20135:01 pmRNSHolding(s) in Company
15th Jul 20133:37 pmRNSDirector/PDMR Shareholding
15th Jul 201310:49 amRNSHolding(s) in Company
12th Jul 201312:50 pmRNSDirector/PDMR Shareholding
10th Jul 20134:31 pmRNSSale of Interest in Treatt plc
10th Jul 20134:28 pmRNSBovill Family Concert Party Placing
31st May 201310:17 amRNSDirector/PDMR Shareholding
28th May 20137:00 amRNSTrading Statement
24th May 201310:54 amRNSDirectorate Change
14th May 201310:56 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSInterim Results
2nd Apr 20138:13 amRNSDirector/PDMR Shareholding
28th Mar 201312:58 pmRNSResult of EGM
28th Mar 20137:00 amRNSTrading Update
20th Mar 20137:00 amRNSShareholder Notification Regarding Treatt PLC
19th Mar 20133:16 pmRNSShareholder notification regarding Treatt plc
13th Mar 20137:23 amRNSDirector/PDMR Shareholding
4th Mar 20132:17 pmRNSNotice of EGM
1st Mar 20134:09 pmRNSHolding(s) in Company
1st Mar 201310:02 amRNSNotice of EGM
26th Feb 201310:02 amRNSResult of AGM
18th Feb 20134:18 pmRNSInterim Management Statement
18th Jan 20134:07 pmRNSDirectorate Change
31st Dec 20127:00 amRNSAnnual Information Update
21st Dec 201210:39 amRNSAnnual Financial Report
17th Dec 201211:33 amRNSDirector/PDMR Shareholding
10th Dec 20127:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.